7 days ago
LLY
AnalystsDavid RisingerDavid Risinger's Stock Forecasts
AnalystsDavid Risinger
Analyst Ranking
Top 7%
#376 out of 5549 analysts
Average Return
+21.77%
Win Rate
67%60 out of 90
Risk vs Reward
Poor
Good
David Risinger's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Horizon Therapeutics Public Ltd CoHZNP | +184.14% | $31.85 | $90.50 | 2020-04-02 - 2021-04-01 | Strong Buy |
Centessa Pharmaceuticals PLCCNTA | +175.64% | $3.90 | $10.75 | 2023-03-17 - 2024-03-15 | Buy |
Roivant Sciences LtdROIV | +164.94% | $15.09 | $39.98 | 2025-09-18 - 2026-09-17 | Buy |
Roivant Sciences LtdROIV | +164.66% | $3.65 | $9.66 | 2022-05-23 - 2023-05-22 | Buy |
First Tracks Biotherapeutics IncTRAX | +149.89% | $18.16 | $45.38 | 2026-04-24 - 2026-10-27 | Buy |
David Risinger Analyst Color
Get additional color on David Risinger's coverage of popular stocks
23 days ago
BMY
9 months ago
BMY
a year ago
LLY
a year ago
JNJ
3 years ago
LLY
4 years ago
ABBV
4 years ago
PFE
4 years ago
JNJ
David Risinger's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eli Lilly & CoLLY | 15 | Buy | $1,316.00 | +2.66% | Maintains | 7 days ago |
First Tracks Biotherapeutics IncTRAX | 2 | Buy | $90.00 | +98.33% | Maintains | 12 days ago |
Johnson & JohnsonJNJ | 6 | Buy | $272.00 | +1.22% | Maintains | 14 days ago |
Bristol Myers Squibb CoBMY | 6 | Hold | $59.00 | -4.14% | Downgrades | 23 days ago |
Anaptysbio IncANAB | 3 | Buy | $81.00 | +63.21% | Maintains | a month ago |
Entera Bio LtdENTX | 1 | Buy | $9.00 | +194.12% | Initiates Coverage On | a month ago |
Latigo Biotherapeutics IncLTGO | 1 | Buy | $36.00 | +136.69% | Initiates Coverage On | 2 months ago |
Scribe Therapeutics IncSCTX | 1 | Buy | $37.00 | +131.83% | Initiates Coverage On | 2 months ago |
Regeneron Pharmaceuticals IncREGN | 10 | Hold | $824.00 | +0.97% | Maintains | 2 months ago |
Ligand Pharmaceuticals IncLGND | 1 | Buy | $330.00 | +5.86% | Initiates Coverage On | 2 months ago |
Halozyme Therapeutics IncHALO | 5 | Buy | $110.00 | -14.40% | Upgrades | 3 months ago |
Kailera Therapeutics IncKLRA | 1 | Buy | $36.00 | +174.18% | Initiates Coverage On | 6 months ago |
Centessa Pharmaceuticals PLCCNTA | 3 | Hold | $40.00 | -1.23% | Downgrades | 7 months ago |
Oruka Therapeutics IncORKA | 3 | Buy | $86.00 | -10.24% | Maintains | 7 months ago |
Amgen IncAMGN | 6 | Buy | $355.00 | -20.75% | Maintains | 9 months ago |
Vertex Pharmaceuticals IncVRTX | 6 | Buy | $525.00 | +0.76% | Maintains | 10 months ago |
Roivant Sciences LtdROIV | 6 | Buy | $32.00 | -12.42% | Maintains | 10 months ago |
Xoma Royalty CorpXOMA | 1 | Buy | $45.00 | +12.02% | Maintains | a year ago |
Imagenebio IncIMA | 1 | Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Metsera IncMTSR | 2 | Hold | $57.00 | N/A | Downgrades | a year ago |
Abbvie IncABBV | 5 | Buy | $206.00 | N/A | Upgrades | 2 years ago |
Tectonic Therapeutic IncTECX | 2 | Buy | $69.00 | N/A | Maintains | 2 years ago |
Tenax Therapeutics IncTENX | 1 | Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Vaxcyte IncPCVX | 2 | Buy | $153.00 | N/A | Maintains | 2 years ago |
Theravance Biopharma IncTBPH | 3 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Hillevax IncHLVX | 2 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Gilead Sciences IncGILD | 3 | Hold | $91.00 | N/A | Maintains | 4 years ago |
Pfizer IncPFE | 9 | Hold | $48.00 | N/A | Maintains | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 7 | Hold | $116.50 | N/A | Downgrades | 4 years ago |
Radius Health IncRDUS1 | 2 | Hold | $10.00 | N/A | Maintains | 4 years ago |
Organon & CoOGN | 1 | Hold | $33.00 | N/A | Initiates Coverage On | 5 years ago |
Jazz Pharmaceuticals PLCJAZZ | 3 | Hold | $176.00 | N/A | Maintains | 6 years ago |
Viatris IncVTRS | 1 | Hold | $16.00 | N/A | Maintains | 6 years ago |
Perrigo Co PLCPRGO | 5 | Hold | $45.00 | N/A | Maintains | 6 years ago |
Endo International PLCENDPQ | 2 | Strong Sell | $7.00 | N/A | Maintains | 6 years ago |
Bausch Health Companies IncBHC | 1 | Hold | $35.00 | N/A | Maintains | 6 years ago |
Elanco Animal Health IncELAN | 2 | Strong Buy | $31.00 | N/A | Upgrades | 6 years ago |
Royalty Pharma PLCRPRX | 1 | Hold | $51.00 | N/A | Initiates Coverage On | 6 years ago |
Zoetis IncZTS | 2 | Hold | $125.00 | N/A | Maintains | 7 years ago |
Teva Pharmaceutical Industries LtdTEVA | 7 | Strong Sell | $8.00 | N/A | Maintains | 7 years ago |
Merck & Co IncMRK | 6 | Strong Buy | $89.00 | N/A | Maintains | 7 years ago |
Alkermes PLCALKS | 1 | Hold | $16.00 | N/A | Maintains | 7 years ago |
Allergan PLCAGN | 6 | Hold | $156.00 | N/A | Downgrades | 8 years ago |
Amneal Pharmaceuticals IncAMRX | 1 | Hold | $18.00 | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.